[Fludrocortisone resistance in a patient with Addison disease and bipolar disorder treated with lithium].
Gómez-Herreros
Rocío
R
Gotor Sánchez-Luengo
Francisco
F
del Valle-Villagrán
José
J
Fernández-López
Ignacio
I
D000224:Addison Disease / Q000150:complications / Q000188:drug therapy*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D004347:Drug Interactions; D004351:Drug Resistance / Q000187:drug effects*; D004830:Epilepsy, Tonic-Clonic / Q000209:etiology; D005438:Fludrocortisone / Q000494:pharmacology* / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007010:Hyponatremia / Q000209:etiology; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000494:pharmacology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use
D016651:Lithium Carbonate; D000324:Adrenocorticotropic Hormone; D006220:Haloperidol; D005438:Fludrocortisone; D011241:Prednisone; D006854:Hydrocortisone